361 Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,330
Closed -$748K 346
2020
Q1
$748K Buy
8,330
+2,147
+35% +$278K 0.34% 129
2019
Q4
$914K Buy
+6,183
New +$830K 0.25% 227
2019
Q3
Sell
-10,665
Closed -$1.44M 337
2019
Q2
$1.44M Buy
+10,665
New +$1.35M 0.26% 185
2019
Q1
Sell
-10,585
Closed -$1.32M 357
2018
Q4
$1.32M Sell
10,585
-5,042
-32% -$677K 0.27% 182
2018
Q3
$2.17M Buy
+15,627
New +$1.95M 0.47% 37
2017
Q2
Sell
-55,570
Closed -$4.95M 185
2017
Q1
$4.95M Buy
55,570
+8,810
+19% +$735K 1.06% 42
2016
Q4
$3.46M Buy
+46,760
New +$3.5M 0.82% 57

Other funds holding HCA

361 Capital's HCA Position: Q2 2020 in Review

361 Capital sold out of HCA Healthcare (HCA) in Q2 2020, closing a stake of 8,330 shares — an estimated $748K sold.

361 Capital first reported a position in HCA in Q4 2016 and held it in 7 quarters. The position peaked at $4.95M in Q1 2017. 686 funds tracked by Wall St. Rank hold HCA as of Q2 2020.

  • 361 Capital reported no remaining HCA Healthcare position as of Q2 2020 after selling out during the quarter.
  • 361 Capital sold 8,330 HCA Healthcare shares in Q2 2020, an estimated $748K.
  • 361 Capital first reported a position in HCA Healthcare in Q4 2016 and held it in 7 quarters.
  • 361 Capital's HCA Healthcare position peaked at $4.95M in Q1 2017.
  • 686 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.